Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
LYMPHOGENiX Logo
LYMPHOGENiX Growth Score
49
CB Rank
97338
Heat Score
61
LYMPHOGENiX aim to be a global leader in lymphatic science, addressing unmet needs in both human and animal health.
Founded
obfuscation
PrivatePre-Seed Covent Garden, Essex, United Kingdom1-10 www.lymphogenix.com/
Biotechnology
Health Care
Medical
Overview

LYMPHOGENiX
Total Funding
obfuscation
Growth Score
49
Heat Score
61

Total Funding
obfuscation
obfuscation
Pre-Seed raised
obfuscation
Growth Score49
-13 pts
in past quarter
Heat Score 61
2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About LYMPHOGENiX

CB Rank
97338
LYMPHOGENiX aim to be a global leader in lymphatic science, addressing unmet needs in both human and animal health.
Founded
obfuscation
PrivatePre-Seed Covent Garden, Essex, United Kingdom1-10 www.lymphogenix.com/
Biotechnology
Health Care
Medical

Funding Rounds

Pre-Seed
OBF
in
obfuscation

Details

Operating Status Active
Company Type For Profit
About the Company
LYMPHOGENiX aspires to be a global leader in lymphatic science, addressing unmet needs in both human and animal health. Our purpose is to unleash the lymphatic system's latent potential to tackle real-world health concerns.
Contact Email info@lymphogenix.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Vessely
A therapeutic candidate designed to enhance endometrial lymphatic health to improve fertility outcomes in both human and veterinary medicine.
Therapeutic Development Services
Services focused on developing therapies that restore or enhance lymphatic function for human and animal health applications.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Pre Seed Round - LYMPHOGENiX Logo
Pre Seed Round - LYMPHOGENiX
4
obfuscation
Keio Innovation InitiativePre-Seed
obfuscation
Pre Seed Round - LYMPHOGENiX Logo
Pre Seed Round - LYMPHOGENiX
4
obfuscation
Keio Innovation InitiativePre-Seed
obfuscation
Pre Seed Round - LYMPHOGENiX Logo
Pre Seed Round - LYMPHOGENiX
4
obfuscation
Keio Innovation InitiativePre-Seed
obfuscation
Pre Seed Round - LYMPHOGENiX Logo
Pre Seed Round - LYMPHOGENiX
4
obfuscation
Keio Innovation InitiativePre-Seed
obfuscation
Pre Seed Round - LYMPHOGENiX Logo
Pre Seed Round - LYMPHOGENiX
4
obfuscation
Keio Innovation InitiativePre-Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Pre Seed Round - LYMPHOGENiX Logo
Pre Seed Round - LYMPHOGENiX
4
obfuscation
Keio Innovation InitiativePre-Seed
obfuscation
Pre Seed Round - LYMPHOGENiX Logo
Pre Seed Round - LYMPHOGENiX
4
obfuscation
Keio Innovation InitiativePre-Seed
obfuscation
Pre Seed Round - LYMPHOGENiX Logo
Pre Seed Round - LYMPHOGENiX
4
obfuscation
Keio Innovation InitiativePre-Seed
obfuscation
Pre Seed Round - LYMPHOGENiX Logo
Pre Seed Round - LYMPHOGENiX
4
obfuscation
Keio Innovation InitiativePre-Seed
obfuscation
Pre Seed Round - LYMPHOGENiX Logo
Pre Seed Round - LYMPHOGENiX
4
obfuscation
Keio Innovation InitiativePre-Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News
Technology
View Tech Report

Active Website Tech Count

1LYMPHOGENiX is actively using the technology DNSSEC for its website, according to BuiltWith.

Total IP

2The intellectual property of LYMPHOGENiX includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is LYMPHOGENiX's headquarters? LYMPHOGENiX is located in Covent Garden, Essex, United Kingdom.Who invested in LYMPHOGENiX? LYMPHOGENiX has 4 investors including Glocalink and  Keio Innovation Initiative.When was the last funding round for LYMPHOGENiX? LYMPHOGENiX closed its last funding round on
obfuscation
from a Pre-Seed round.Who are LYMPHOGENiX's competitors? Alternatives and possible competitors to LYMPHOGENiX may include Tivic Health, BD, and  ATB Therapeutics.How much funding has LYMPHOGENiX raised to date? LYMPHOGENiX has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|